{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:19:19Z","timestamp":1707524359916},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,9,3]]},"DOI":"10.7759\/cureus.17685","type":"journal-article","created":{"date-parts":[[2021,9,6]],"date-time":"2021-09-06T17:30:09Z","timestamp":1630949409000},"source":"Crossref","is-referenced-by-count":0,"title":["Memantine for the Treatment of Behavioral Disturbance in Unspecified Major Neurocognitive Disorder"],"prefix":"10.7759","author":[{"given":"Peyton H","family":"Terry","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kareem","family":"Seoudy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meredith S","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keri A","family":"Stevenson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2012.11.007","article-title":"The global prevalence of dementia: a systematic review and metaanalysis","volume":"9","author":"Prince M","year":"2013","unstructured":"Prince M, Bryce R, Albanese E, Wimo A, Ribeiro W, Ferri CP. The global prevalence of dementia: a systematic review and metaanalysis. Alzheimers Dement. 2013, 9:63-75. 10.1016\/j.jalz.2012.11.007","journal-title":"Alzheimers Dement"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1159\/000448806","article-title":"Characteristics associated with quality of life in long-term care residents with dementia: a cross-sectional study","volume":"42","author":"Klapwijk MS","year":"2016","unstructured":"Klapwijk MS, Caljouw MA, Pieper MJ, van der Steen JT, Achterberg WP. Characteristics associated with quality of life in long-term care residents with dementia: a cross-sectional study. Dement Geriatr Cogn Disord. 2016, 42:186-97. 10.1159\/000448806","journal-title":"Dement Geriatr Cogn Disord"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-017-0818-2","article-title":"Dementia caregiver burden: a research update and critical analysis","volume":"19","author":"Cheng ST","year":"2017","unstructured":"Cheng ST. Dementia caregiver burden: a research update and critical analysis. Curr Psychiatry Rep. 2017, 19:64. 10.1007\/s11920-017-0818-2","journal-title":"Curr Psychiatry Rep"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S142839","article-title":"The effects of memantine on behavioral disturbances in patients with Alzheimer's disease: a meta-analysis","volume":"13","author":"Kishi T","year":"2017","unstructured":"Kishi T, Matsunaga S, Iwata N. The effects of memantine on behavioral disturbances in patients with Alzheimer's disease: a meta-analysis. Neuropsychiatr Dis Treat. 2017, 13:1909-28. 10.2147\/NDT.S142839","journal-title":"Neuropsychiatr Dis Treat"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1099-1166(199902)14:2<135::aid-gps906>3.0.co;2-0","article-title":"Memantine in severe dementia: results of the 9M-best study (benefit and efficacy in severely demented patients during treatment with memantine)","volume":"14","author":"Winblad B","year":"1999","unstructured":"Winblad B, Poritis N. Memantine in severe dementia: results of the 9M-best study (benefit and efficacy in severely demented patients during treatment with memantine). Int J Geriatr Psychiatry. 1999, 14:135-46. 10.1002\/(sici)1099-1166(199902)14:2&lt;135::aid-gps906&gt;3.0.co;2-0","journal-title":"Int J Geriatr Psychiatry"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa013128","article-title":"Memantine in moderate-to-severe Alzheimer's disease","volume":"348","author":"Reisberg B","year":"2003","unstructured":"Reisberg B, Doody R, St\u00f6ffler A, Schmitt F, Ferris S, M\u00f6bius HJ. Memantine in moderate-to-severe Alzheimer's disease. N Engl J Med. 2003, 348:1333-41. 10.1056\/NEJMoa013128","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1001\/jama.291.3.317","article-title":"Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial","volume":"291","author":"Tariot PN","year":"2004","unstructured":"Tariot PN, Farlow MR, Grossberg GT, Graham SM, McDonald S, Gergel I. Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial. JAMA. 2004, 291:317-24. 10.1001\/jama.291.3.317","journal-title":"JAMA"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2147\/cia.s6666","article-title":"Memantine: a review of studies into its safety and efficacy in treating Alzheimer's disease and other dementias","volume":"4","author":"Thomas SJ","year":"2009","unstructured":"Thomas SJ, Grossberg GT. Memantine: a review of studies into its safety and efficacy in treating Alzheimer's disease and other dementias. Clin Interv Aging. 2009, 4:367-77. 10.2147\/cia.s6666","journal-title":"Clin Interv Aging"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(07)70195-3","article-title":"Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomised controlled trials","volume":"6","author":"Kavirajan H","year":"2007","unstructured":"Kavirajan H, Schneider LS. Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomised controlled trials. Lancet Neurol. 2007, 6:782-92. 10.1016\/S1474-4422(07)70195-3","journal-title":"Lancet Neurol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3233\/jad-2005-7403","article-title":"The use of memantine in dementia with Lewy bodies","volume":"7","author":"Sabbagh MN","year":"2005","unstructured":"Sabbagh MN, Hake AM, Ahmed S, Farlow MR. The use of memantine in dementia with Lewy bodies. J Alzheimers Dis. 2005, 7:285-9. 10.3233\/jad-2005-7403","journal-title":"J Alzheimers Dis"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000172351.95783.8e","article-title":"Delusions and hallucinations in dementia with Lewy bodies: worsening with memantine","volume":"65","author":"Ridha BH","year":"2005","unstructured":"Ridha BH, Josephs KA, Rossor MN. Delusions and hallucinations in dementia with Lewy bodies: worsening with memantine. Neurology. 2005, 65:481-2. 10.1212\/01.wnl.0000172351.95783.8e","journal-title":"Neurology"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(10)70194-0","article-title":"Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial","volume":"9","author":"Emre M","year":"2010","unstructured":"Emre M, Tsolaki M, Bonuccelli U, et al.. Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial. Lancet Neurology. 2010, 9:969-77. 10.1016\/S1474-4422(10)70194-0","journal-title":"Lancet Neurology"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/gps.1973","article-title":"A 6-month, open-label study of memantine in patients with frontotemporal dementia","volume":"23","author":"Diehl-Schmid J","year":"2008","unstructured":"Diehl-Schmid J, F\u00f6rstl H, Perneczky R, Pohl C, Kurz A. A 6-month, open-label study of memantine in patients with frontotemporal dementia. Int J Geriatr Psychiatry. 2008, 23:754-9. 10.1002\/gps.1973","journal-title":"Int J Geriatr Psychiatry"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32813384e8","article-title":"Memantine and HIV-associated cognitive impairment: a neuropsychological and proton magnetic resonance spectroscopy study","volume":"21","author":"Schifitto G","year":"2007","unstructured":"Schifitto G, Navia BA, Yiannoutsos CT, et al.. Memantine and HIV-associated cognitive impairment: a neuropsychological and proton magnetic resonance spectroscopy study. AIDS. 2007, 21:1877-86. 10.1097\/QAD.0b013e32813384e8","journal-title":"AIDS"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003154.pub6","article-title":"Memantine for dementia","volume":"3","author":"McShane R","year":"2019","unstructured":"McShane R, Westby MJ, Roberts E, et al.. Memantine for dementia. Cochrane Database Syst Rev. 2019, 3:CD003154. 10.1002\/14651858.CD003154.pub6","journal-title":"Cochrane Database Syst Rev"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2007.07.008","article-title":"Addition of memantine to antipsychotic treatment in schizophrenia inpatients with residual symptoms: a preliminary study","volume":"18","author":"Krivoy A","year":"2008","unstructured":"Krivoy A, Weizman A, Laor L, Hellinger N, Zemishlany Z, Fischel T. Addition of memantine to antipsychotic treatment in schizophrenia inpatients with residual symptoms: a preliminary study. Eur Neuropsychopharmacol. 2008, 18:117-21. 10.1016\/j.euroneuro.2007.07.008","journal-title":"Eur Neuropsychopharmacol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291716000398","article-title":"Memantine augmentation in clozapine-refractory schizophrenia: a randomized, double-blind, placebo-controlled crossover study","volume":"46","author":"Veerman SR","year":"2016","unstructured":"Veerman SR, Schulte PF, Smith JD, de Haan L. Memantine augmentation in clozapine-refractory schizophrenia: a randomized, double-blind, placebo-controlled crossover study. Psychol Med. 2016, 46:1909-21. 10.1017\/S0033291716000398","journal-title":"Psychol Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291716002476","article-title":"Adjunctive memantine in clozapine-treated refractory schizophrenia: an open-label 1-year extension study","volume":"47","author":"Veerman SR","year":"2017","unstructured":"Veerman SR, Schulte PF, Deijen JB, de Haan L. Adjunctive memantine in clozapine-treated refractory schizophrenia: an open-label 1-year extension study. Psychol Med. 2017, 47:363-75. 10.1017\/S0033291716002476","journal-title":"Psychol Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-015-2221-2","article-title":"Efficacy and adverse effects of memantine treatment for Alzheimer's disease from randomized controlled trials","volume":"36","author":"Jiang J","year":"2015","unstructured":"Jiang J, Jiang H. Efficacy and adverse effects of memantine treatment for Alzheimer's disease from randomized controlled trials. Neurol Sci. 2015, 36:1633-41. 10.1007\/s10072-015-2221-2","journal-title":"Neurol Sci"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2018.1524870","article-title":"The efficacy and safety of memantine for the treatment of Alzheimer's disease","volume":"17","author":"Matsunaga S","year":"2018","unstructured":"Matsunaga S, Kishi T, Nomura I, Sakuma K, Okuya M, Ikuta T, Iwata N. The efficacy and safety of memantine for the treatment of Alzheimer's disease. Expert Opin Drug Saf. 2018, 17:1053-61. 10.1080\/14740338.2018.1524870","journal-title":"Expert Opin Drug Saf"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/66759-memantine-for-the-treatment-of-behavioral-disturbance-in-unspecified-major-neurocognitive-disorder","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:30:42Z","timestamp":1707507042000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/66759-memantine-for-the-treatment-of-behavioral-disturbance-in-unspecified-major-neurocognitive-disorder"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,3]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.17685","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9,3]]}}}